1
|
Dettori M, Riccardi N, Canetti D, Antonello RM, Piana AF, Palmieri A, Castiglia P, Azara AA, Masia MD, Porcu A, Ginesu GC, Cossu ML, Conti M, Pirina P, Fois A, Maida I, Madeddu G, Babudieri S, Saderi L, Sotgiu G. Infections in lung transplanted patients: A review. Pulmonology 2024; 30:287-304. [PMID: 35710714 DOI: 10.1016/j.pulmoe.2022.04.010] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2021] [Revised: 03/29/2022] [Accepted: 04/25/2022] [Indexed: 02/07/2023] Open
Abstract
Lung transplantation can improve the survival of patients with severe chronic pulmonary disorders. However, the short- and long-term risk of infections can increase morbidity and mortality rates. A non-systematic review was performed to provide the most updated information on pathogen, host, and environment-related factors associated with the occurrence of bacterial, fungal, and viral infections as well as the most appropriate therapeutic options. Bacterial infections account for about 50% of all infectious diseases in lung transplanted patients, while viruses represent the second cause of infection accounting for one third of all infections. Almost 10% of patients develop invasive fungal infections during the first year after lung transplant. Pre-transplantation comorbidities, disruption of physical barriers during the surgery, and exposure to nosocomial pathogens during the hospital stay are directly associated with the occurrence of life-threatening infections. Empiric antimicrobial treatment after the assessment of individual risk factors, local epidemiology of drug-resistant pathogens and possible drug-drug interactions can improve the clinical outcomes.
Collapse
Affiliation(s)
- M Dettori
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - N Riccardi
- StopTB Italia Onlus, Milan, Italy; Department of Clinical and Experimental Medicine, University of Pisa, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy
| | - D Canetti
- StopTB Italia Onlus, Milan, Italy; Department of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - R M Antonello
- Clinical Department of Medical, Surgical and Health Sciences, Trieste University, Trieste, Italy
| | - A F Piana
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - A Palmieri
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - P Castiglia
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - A A Azara
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - M D Masia
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - A Porcu
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - G C Ginesu
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - M L Cossu
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - M Conti
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - P Pirina
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - A Fois
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - I Maida
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - G Madeddu
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - S Babudieri
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - L Saderi
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - G Sotgiu
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy; StopTB Italia Onlus, Milan, Italy.
| |
Collapse
|
2
|
Appolloni L, Gola M, Raffo M, Capasso L, Settimo G, Moscato U, Azara A, Dettori M, Capolongo S, D'Alessandro D. Towards an update of the Italian Ministerial Decree July 5th, 1975. Ann Ig 2021; 32:66-84. [PMID: 33146368 DOI: 10.7416/ai.2020.3395] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
In recent years, the Scientific Community and the Public Health world, in general, have devoted increasing interest to housing conditions, which are considered, to date, one of the main environmental and social determinants of the population's health. In particular, the Scientific Community has identified and studied various indoor well-being factors (e.g. lighting, temperature, ventilation, air quality, etc.). Some of these factors have been regulated by laws and regulations at various levels: the availability of clear and updated health requirements dictated by the regulations is fundamental to effectively protect public health, especially in confined environments. In the present work, we propose a revision of the Italian Ministerial Decree of July 5th, 1975 titled Modificazioni alle istruzioni ministeriali 20 giugno 1896 relativamente all'altezza minima ed ai requisiti igienico sanitari principali dei locali d'abitazione (Modifications to the ministerial instructions of June 20th, 1896 regarding the minimum height and the main hygienic-sanitary requirements of living spaces) in order to update the definition of the essential elements that qualify a space as habitable from the hygienic-sanitary point of view, taking into account the evidence gathered from the technical and scientific literature on the requirements and contents of the Building Codes of the major European countries.
Collapse
Affiliation(s)
- L Appolloni
- Department of Civil Building Environmental engineering (DICEA), Sapienza University of Rome, Rome, Italy
| | - M Gola
- Department of Architecture, Built environment and Construction engineering (DABC), Politecnico di Milano, Milan, Italy
| | - M Raffo
- Servizio Igiene Sanità Pubblica (SISP) - ASL Roma 1, Rome, Italy
| | | | - G Settimo
- National Institute of Health, Rome, Italy
| | - U Moscato
- Fondazione Policlinico Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
| | - A Azara
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - M Dettori
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - S Capolongo
- Department of Architecture, Built environment and Construction engineering (DABC), Politecnico di Milano, Milan, Italy
| | - D D'Alessandro
- Department of Civil Building Environmental engineering (DICEA), Sapienza University of Rome, Rome, Italy
| |
Collapse
|
3
|
Appolloni L, Dettori M, Petronio MG, Raffo M, Settimo G, Rebecchi A, Buffoli M, Capolongo S, D'Alessandro D. A proposal of hygienic and sanitary standards for the new Building Code in Italy. Ann Ig 2020; 32:85-109. [PMID: 33146369 DOI: 10.7416/ai.2020.3396] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
The traditional emphasis of Public Health on the type and quality of housing today merges with other wider determinants of health such as: the neighbourhood, the community and the "place" where a home is located, but also the policies that make access to a healthy home within everyone's reach. At the neighbourhood scale, context-related aspects heavily influence the internal quality and real usability of the buildings themselves, with particular reference to factors such as the quality of the site, the relationship between the building and the context, the presence and quality of the greenery and open spaces surrounding the building, as well as all measures that make it possible to reduce the building's impact on the environment, to protect it against environmental pollution, and to manage the building in an integrated manner for maintenance purposes. Creating healthy living environments means referring to the different dimensions mentioned above, and this not only requires the attention of Public Health operators, but also implies an integration of vision and objectives among various professional skills and competences that puts health at the center of all policies. This proposal, which starts from the analysis of existing local hygiene regulations and scientific literature, aims to take stock of a number of areas considered fundamental for the assessment of building hygiene aspects, with particular reference to the eco-sustainability of buildings and adaptation to climate change. The aspects identified can be considered as a starting point for the preparation of integrated building and hygiene regulations based on documented effective practices for the protection of Public Health.
Collapse
Affiliation(s)
- L Appolloni
- Department of Civil Building Environmental engineering (DICEA), Sapienza University of Rome, Rome, Italy
| | - M Dettori
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - M G Petronio
- Local Health Trust, Region Tuscany Central Area, Florence, Italy
| | - M Raffo
- Public Health Unit, Department of Prevention (SISP), Local Health Trust 1 (ASL RM 1), Rome, Italy
| | - G Settimo
- National Institute of Health, Rome, Italy
| | - A Rebecchi
- Department of Architecture, Built environment and Construction engineering (DABC), Politecnico di Milano, Milan, Italy
| | - M Buffoli
- Department of Architecture, Built environment and Construction engineering (DABC), Politecnico di Milano, Milan, Italy
| | - S Capolongo
- Department of Architecture, Built environment and Construction engineering (DABC), Politecnico di Milano, Milan, Italy
| | - D D'Alessandro
- Department of Civil Building Environmental engineering (DICEA), Sapienza University of Rome, Rome, Italy
| |
Collapse
|
4
|
Lai E, Cremolini C, Puzzoni M, Bergamo F, Zucchelli G, Libertini M, Dettori M, Banzi M, Boccaccino A, Cinieri S, Cavo A, Piacentini G, Andreozzi F, Banna G, Nappo F, Iachetta F, Rota S, Conca V, Zaniboni A, Scartozzi M. 447P Long term survival with regorafenib: REALITY (real life in Italy) trial - A GISCAD Study. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.558] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
5
|
Gugliotta C, Deiana G, Dettori M, Sotgiu G, Azara A, Castiglia P. Prevalence study on health-care associated infections and on the use of antimicrobials carried out with the light protocol of the European Centre for Disease Prevention and Control. Ann Ig 2020; 32:357-367. [PMID: 32744294 DOI: 10.7416/ai.2020.2359] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BACKGROUND Prevalence surveys can be helpful to assess Health-care Associated Infections and antimicrobial use in healthcare settings, as well as infection control interventions. The aim of this study was to estimate the prevalence of both Health-care Associated Infections and antimicrobial use in acute care wards in the University Hospital of Sassari according to the European Centre for Disease Prevention and Control light protocol. METHODS According to the case-finding algorithm, information was collected only if the patient had received at least one antimicrobial at the time of the survey or if the patient had an active infection associated with an acute care hospital stay. Data were collected over a span of a week, on a single day for every ward. RESULTS The survey included 588 patients. A total number of 49 Health-care Associated Infections were observed on 43 patients with an overall prevalence of 7.3%. Urinary tract infections were the most common Health-care Associated Infection. The antimicrobial use prevalence was 44.6%. Results for microbiological investigation were available for 27 Health-care Associated Infections (55.1%) with 36 identified microorganisms. A total of 343 antimicrobials were administered, mainly for the treatment of an infection (57.4%). Combinations of penicillins, including beta-lactamase inhibitors, were the most frequently prescribed (35.0%). CONCLUSIONS To our best knowledge, this is the first prevalence study carried out in Italy following the light protocol. This study suggests that the prevalence of patients with Health-care Associated Infections in our hospital is slightly higher than the one observed by the European Centre for Disease Prevention and Control point prevalence survey of 2011, and lower than the one observed in the last national survey of 2016. The European Centre for Disease Prevention and Control light protocol proved applicable in acute-care hospitals with high complexity of structures and particular distribution of wards in order to perform a point prevalence study more quickly, without decreasing its value and its comparability to other similar studies.
Collapse
Affiliation(s)
- C Gugliotta
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - G Deiana
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - M Dettori
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - G Sotgiu
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - A Azara
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| | - P Castiglia
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
| |
Collapse
|
6
|
Lai E, Liscia N, Donisi C, Mariani S, Tolu S, Pretta A, Persano M, Pinna G, Balconi F, Pireddu A, Impera V, Dubois M, Migliari M, Spanu D, Saba G, Camera S, Musio F, Ziranu P, Puzzoni M, Demurtas L, Pusceddu V, Dettori M, Massa E, Atzori F, Dessì M, Astara G, Madeddu C, Scartozzi M. Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer. Cancers (Basel) 2020; 12:E1214. [PMID: 32413973 PMCID: PMC7281737 DOI: 10.3390/cancers12051214] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2020] [Revised: 05/03/2020] [Accepted: 05/07/2020] [Indexed: 12/12/2022] Open
Abstract
BACKGROUND Metastatic CRC (mCRC) is a molecular heterogeneous disease. The aim of this review is to give an overview of molecular-driven treatment of mCRC patients. METHODS A review of clinical trials, retrospective studies and case reports was performed regarding molecular biomarkers with therapeutic implications. RESULTS RAS wild-type status was confirmed as being crucial for anti-epidermal growth factor receptor (EGFR) monoclonal antibodies and for rechallenge strategy. Antiangiogenic therapies improve survival in first- and second-line settings, irrespective of RAS status, while tyrosine kinase inhibitors (TKIs) remain promising in refractory mCRC. Promising results emerged from anti-HER2 drugs trials in HER2-positive mCRC. Target inhibitors were successful for BRAFV600E mutant mCRC patients, while immunotherapy was successful for microsatellite instability-high/defective mismatch repair (MSI-H/dMMR) or DNA polymerase epsilon catalytic subunit (POLE-1) mutant patients. Data are still lacking on NTRK, RET, MGMT, and TGF-β, which require further research. CONCLUSION Several molecular biomarkers have been identified for the tailored treatment of mCRC patients and multiple efforts are currently ongoing to increase the therapeutic options. In the era of precision medicine, molecular-biology-driven treatment is the key to impro patient selection and patient outcomes. Further research and large phase III trials are required to ameliorate the therapeutic management of these patients.
Collapse
Affiliation(s)
- Eleonora Lai
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| | - Nicole Liscia
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
- Medical Oncology Unit, Sapienza University of Rome, 00161 Rome, Italy
| | - Clelia Donisi
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| | - Stefano Mariani
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| | - Simona Tolu
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
- Medical Oncology Unit, Sapienza University of Rome, 00161 Rome, Italy
| | - Andrea Pretta
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
- Medical Oncology Unit, Sapienza University of Rome, 00161 Rome, Italy
| | - Mara Persano
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| | - Giovanna Pinna
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| | - Francesca Balconi
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| | - Annagrazia Pireddu
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
- Medical Oncology Unit, Sapienza University of Rome, 00161 Rome, Italy
| | - Valentino Impera
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
- Medical Oncology Unit, Sapienza University of Rome, 00161 Rome, Italy
| | - Marco Dubois
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| | - Marco Migliari
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| | - Dario Spanu
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| | - Giorgio Saba
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| | - Silvia Camera
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
- Medical Oncology Unit, Sapienza University of Rome, 00161 Rome, Italy
| | - Francesca Musio
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| | - Pina Ziranu
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| | - Marco Puzzoni
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| | - Laura Demurtas
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| | - Valeria Pusceddu
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| | - Manuela Dettori
- Medical Oncology Unit, Azienda Ospedaliera Brotzu, Ospedale Businco, 09134 Cagliari, Italy
| | - Elena Massa
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| | - Francesco Atzori
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| | - Mariele Dessì
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| | - Giorgio Astara
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| | - Clelia Madeddu
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| | - Mario Scartozzi
- Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy; (E.L.); (N.L.); (C.D.); (S.M.); (S.T.); (A.P.); (M.P.); (G.P.); (F.B.); (A.P.); (V.I.); (M.D.); (M.M.); (D.S.); (G.S.); (S.C.); (F.M.); (P.Z.); (M.P.); (L.D.); (V.P.); (E.M.); (F.A.); (M.D.); (G.A.); (C.M.)
| |
Collapse
|
7
|
Azara A, Castiglia P, Piana A, Masia MD, Palmieri A, Arru B, Maida G, Dettori M. Derogation from drinking water quality standards in Italy according to the European Directive 98/83/EC and the Legislative Decree 31/2001 - a look at the recent past. Ann Ig 2019; 30:517-526. [PMID: 30614501 DOI: 10.7416/ai.2018.2252] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BACKGROUND Until 2012, the European Directive 98/83/EC and the Italian Legislative Decree 31/2001 allowed derogation from the drinking water quality standards in Italy with a number of requests higher than any other European country. The present work aims to assess the extent of the derogation granted in Italy, in particular by noting those issued from 2001 to 2012, in order to obtain a retrospective quality indicator, useful for evaluating the risk arising from population exposure. METHODS The most significant factors leading to derogation were analyzed. We first carried out an in-depth analysis of the European, national and regional legislation and subsequently distributed the obtained data according to: parameters regarding derogation; length of the derogation; area involved; and maximum parameter value granted by the derogation acts. RESULTS We found approximately 100 derogation acts, granted in 14 Regions and concerning 19, mostly chemical, parameters. The most frequently granted derogation, in 12 Regions, was due to the presence of arsenic. Furthermore, given its 10-year presence in Campania and Lazio, fluoride was the most widespread parameter in the Italian territory. The year 2006 had the largest number of derogations issued with 22 acts found: this decreased to one during the third three-year derogation granted in 2012. CONCLUSIONS Data collected showed how often Italy applied for drinking water quality derogation in recent years, going so far as to request a third three-year derogation. While this phenomenon has highlighted a practice largely ignored by the public, derogation acts have often involved the same parameters, underlining how difficult it can be to comply with the standards in a timely manner.
Collapse
Affiliation(s)
- A Azara
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
| | - P Castiglia
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
| | - A Piana
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
| | - M D Masia
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
| | - A Palmieri
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
| | - B Arru
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
| | - G Maida
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
| | - M Dettori
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
| |
Collapse
|
8
|
D'Alessandro D, Arletti S, Azara A, Buffoli M, Capasso L, Cappuccitti A, Casuccio A, Cecchini A, Costa G, De Martino AM, Dettori M, Di Rosa E, Fara GM, Ferrante M, Giammanco G, Lauria A, Melis G, Moscato U, Oberti I, Patrizio C, Petronio MG, Rebecchi A, Romano Spica V, Settimo G, Signorelli C, Capolongo S. Strategies for Disease Prevention and Health Promotion in Urban Areas: The Erice 50 Charter. Ann Ig 2018; 29:481-493. [PMID: 29048447 DOI: 10.7416/ai.2017.2179] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
The Erice 50 Charter titled "Strategies for Diseases Prevention and Health Promotion in Urban Areas" was unanimously approved at the conclusion of the 50th Residential Course "Urban Health. Instruments for promoting health and for assessing hygienic and sanitary conditions in urban areas", held from 29th March to 2nd April 2017 in Erice, at the "Ettore Majorana" Foundation and Centre for Scientific Culture and promoted by the International School of Epidemiology and Preventive Medicine "G. D'Alessandro" and the Study Group "Building Hygiene" of the Italian Society of Hygiene, Preventive Medicine and Public Health (SItI). At the conclusion of the intense learning experience during the Course, with more than 20 lectures, workshops and long-lasting discussions between Professors and Students, the participants identified the major points connecting urban features and Public Health, claiming the pivotal role of urban planning strategies for the management of Diseases Prevention and Health Promotion activities. The Erice 50 Charter is configured as a Decalogue for Healthy Cities and as a Think Tank for designing effective strategic actions and best practices to develop urban regeneration interventions and improve the urban quality of contemporary cities. The Decalogue is structured into the following key strategic objectives: 1. Promoting urban planning interventions that address citizens towards healthy behaviours; 2. Improving living conditions in the urban context; 3. Building an accessible and inclusive city, with a special focus on the frail population; 4. Encouraging the foundation of resilient urban areas; 5. Supporting the development of new economies and employment through urban renewal interventions; 6. Tackling social inequalities; 7. Improving stakeholders' awareness of the factors affecting Public Health in the cities; 8. Ensuring a participated urban governance; 9. Introducing qualitative and quantitative performance tools, capable of measuring the city's attitude to promote healthy lifestyles and to monitor the population's health status; 10. Encouraging sharing of knowledge and accessibility to informations. Finally, all the participants underlined that a multidisciplinary team, composed of Physicians specialized in Hygiene, Preventive Medicine, Public Health and Technicians as Architects, Urban planners and Engineers, is needed to deepen the research topic of Urban Health.
Collapse
Affiliation(s)
| | - S Arletti
- Rete Italiana Città Sane, Modena, Italy
| | - A Azara
- Università degli Studi di Sassari, Sassari, Italy
| | | | - L Capasso
- Università degli Studi di Pavia, Pavia, Italy
| | | | - A Casuccio
- Università degli Studi di Palermo, Palermo, Italy
| | - A Cecchini
- Università degli Studi di Sassari, Sassari, Italy
| | - G Costa
- Università degli Studi di Torino, Turin, Italy
| | | | - M Dettori
- Università degli Studi di Sassari, Sassari, Italy
| | - E Di Rosa
- Azienda Sanitaria Locale Roma 1, Rome, Italy
| | - G M Fara
- Sapienza Università di Roma, Rome, Italy
| | - M Ferrante
- Università degli Studi di Catania, Catania, Italy
| | - G Giammanco
- Università degli Studi di Catania, Catania, Italy
| | - A Lauria
- Unità Sanitaria Locale 20 Verona, Verona, Italy
| | - G Melis
- Istituto Superiore sui Sistemi Territoriali per l'Innovazione (SiTI), Turin, Italy
| | - U Moscato
- Università Cattolica del Sacro Cuore, Rome, Italy
| | - I Oberti
- Politecnico di Milano, Milan, Italy
| | - C Patrizio
- Sapienza Università di Roma, Rome, Italy
| | | | | | | | - G Settimo
- Istituto Superiore di Sanità (ISS), Rome, Italy
| | | | | | | |
Collapse
|
9
|
Sotgiu G, Are BM, Pesapane L, Palmieri A, Muresu N, Cossu A, Dettori M, Azara A, Mura II, Cocuzza C, Aliberti S, Piana A. Nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae in an Italian university hospital: a molecular epidemiological study. J Hosp Infect 2018; 99:413-418. [PMID: 29621600 DOI: 10.1016/j.jhin.2018.03.033] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2018] [Accepted: 03/26/2018] [Indexed: 10/17/2022]
Abstract
AIM To describe the phenotypic and genotypic profiles of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-Kp) strains isolated from patients with invasive infections at an Italian university hospital in order to assess the epidemiological trend. METHODS An observational prospective study was undertaken at the University Hospital of Sassari, Italy to detect KPC-Kp strains in patients with invasive bacteraemia. Isolates were identified phenotypically; carbapenemase production was assessed using phenotypic and genotypic methods. Sequencing of blaKPC genes, pulsed-field gel electrophoresis and multi-locus sequence typing were performed. RESULTS During the period 2015-2017, 46 cases of invasive infection with K. pneumoniae were recorded. Two-thirds (67.4%) of the patients were male, and the mean age was 69.4 years. Most patients had at least one comorbidity (56.5%) and/or had been hospitalized previously (70.5%), 81.8% had current or recent medical device use, and 85.4% had recent antibiotic exposure. The mortality rate was 52.3%. A multi-drug-resistant pattern (including carbapenems, fluoroquinolones, third-/fourth-generation cephalosporins) was shown for all K. pneumoniae isolates. KPC-3 and -2 were produced by all strains. The most common sequence types were 512 (91.3%) and 101 (8.7%), grouped into three clusters (A, A1 and B). CONCLUSIONS A high incidence of KPC-Kp in patients with invasive infections was recorded at an Italian university hospital compared with the incidence measured before 2015. This study confirmed the importance of the KPC-3 carbapenemase variant, as reported by other Italian studies. High mortality and comorbidity rates appear to be associated with KPC-Kp infection.
Collapse
Affiliation(s)
- G Sotgiu
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy; Hygiene and Preventive Medicine Unit, AOU Sassari, Sassari, Italy.
| | - B M Are
- Hygiene and Preventive Medicine Unit, AOU Sassari, Sassari, Italy
| | - L Pesapane
- Hygiene and Preventive Medicine Unit, AOU Sassari, Sassari, Italy
| | - A Palmieri
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy; Hygiene and Preventive Medicine Unit, AOU Sassari, Sassari, Italy
| | - N Muresu
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
| | - A Cossu
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
| | - M Dettori
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
| | - A Azara
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy; Hygiene and Preventive Medicine Unit, AOU Sassari, Sassari, Italy
| | - I I Mura
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy; Hygiene and Preventive Medicine Unit, AOU Sassari, Sassari, Italy
| | - C Cocuzza
- Department of Surgery and Translational Medicine, University of Milan Bicocca, Milan, Italy
| | - S Aliberti
- Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Centre, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - A Piana
- Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy; Hygiene and Preventive Medicine Unit, AOU Sassari, Sassari, Italy
| |
Collapse
|
10
|
Dettori M, Piana A, Castiglia P, Loria E, Azara A. Qualitative and quantitative aspects of drinking water supply in Sardinia, Italy. A descriptive analysis of the ordinances and public notices issued during the years 2010-2015. Ann Ig 2017; 28:296-303. [PMID: 27479766 DOI: 10.7416/ai.2016.2109] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BACKGROUND The aim of the study is to analyze the regional district ordinances and the warnings regarding qualitative and quantitavive drinking water abnormalities discovered by the Sardinian Municipalities and the Water Managing Authority between 2010 and 2015 in order to describe and identify the causes leading to an interruption or a limitation of the drinking water supply. METHODS We carefully reviewed all ordinances and warnings of non-potable water and service interruption published between 2010 and 2015 by the websites of 377 Sardinian Municipalities and by the main regional newspapers, the Water Managing Authority and the Regional Health Trusts. RESULTS From 2010 to 2015, 738 warnings/ordinances regarding drinking water supply limitation or interruption were issued. The warnings involved more than half (n. 191, 50.7%) of the 377 Sardinian Municipalities. Considering that these Municipalities included the main Sardinian cities we estimated that 80.3% of the population was affected by the issue. During the 6 years we observed a progressive increase of Municipalities involved beginning with 25 and reaching up 110 in 2014. The initial 29 warnings rose to 256 in 2014 along with an increased number of abnormal values, parameters and standards of the drinking water. Regarding the ordinances issued by the 191 Mayors we noticed that the legal limits were exceeded in 23 cases. Among those, we underline the abnormal levels of chlorites and trihalomethanes (22% of cases), the turbidity, the abnormal concentration of total chemical substances and the abnormal level of coliforms, Escherichia coli, manganese, aluminum, nitrites and iron. CONCLUSIONS According to our observations, the Sardinian drinking water supply system is affected by a major inconvenience and the data suggest that qualitative abnormalities are mainly due to water purification treatments used in addition to the poor water supply network in existence. Considering these results, a cooperation between all Authorities involved would be desirable in order to analyze official data and provide a careful evaluation of population exposure and real risks related to the level of every parameter considered.
Collapse
Affiliation(s)
- M Dettori
- MSc, Department of Architecture, Design and Urban Planning, University of Sassari, Alghero, Italy
| | - A Piana
- PhD, Department of Biomedical Science, Hygiene and Preventive Medicine, University of Sassari, Sassari, Italy
| | - P Castiglia
- PhD, Department of Biomedical Science, Hygiene and Preventive Medicine, University of Sassari, Sassari, Italy
| | - E Loria
- Department of Architecture, Design and Urban Planning, University of Sassari, Alghero, Italy
| | - A Azara
- MD, MPH, Department of Biomedical Science, Hygiene and Preventive Medicine, University of Sassari, Sassari, Italy
| |
Collapse
|
11
|
Muntoni M, Aloi M, Capra D, Defraia E, Dettori M, Mascia L, Lanzillo A. Aflibercept in combination with FOLFIRI for the 2nd-line treatment of patients with metastatic colorectal cancer (MCRC): safety data from a single institute experience. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx422.042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
12
|
La Jeunesse I, Cirelli C, Aubin D, Larrue C, Sellami H, Afifi S, Bellin A, Benabdallah S, Bird DN, Deidda R, Dettori M, Engin G, Herrmann F, Ludwig R, Mabrouk B, Majone B, Paniconi C, Soddu A. Is climate change a threat for water uses in the Mediterranean region? Results from a survey at local scale. Sci Total Environ 2016; 543:981-996. [PMID: 25956206 DOI: 10.1016/j.scitotenv.2015.04.062] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/09/2015] [Revised: 04/09/2015] [Accepted: 04/15/2015] [Indexed: 06/04/2023]
Abstract
Water scarcity and water security are linked, not only through the direct effects of water shortages on each water users' access to water, but also because of water conflicts generated. Climate change is predicted to raise temperatures in the Mediterranean region and reduce rainfall, leading to a reduction in water yield and possibly worsening the situation of water resource shortages that Mediterranean regions are already experiencing. In its dissemination strategy, the EU FP7 CLIMB project addressed water security threats through an analysis of water uses and water use rivalries within a few target catchments distributed over the Mediterranean region. The present work explores whether climate change is locally perceived by stakeholders (water users and managers) as a key issue for their water uses and water security. Individual interviews, meetings, and compilation of questionnaires were conducted at five sites located in the Mediterranean region. The methodology permitted an analysis of water use and its evolution in the water management context, an identification of the state of awareness of local stakeholders and of the pressures on water use and water use rivalries, and a prioritization of water uses. Currently, the main response to increasing water demand in the Mediterranean region, while not yet considering climate change as a driving force, is a progressive externalization of water resources, with limits represented by national borders and technological possibilities. Overall, 'climate change' was not mentioned by stakeholders during both interviews and in answers to the questionnaires. Even the prospect of decreasing precipitation was not considered a relevant or threatening issue in the coming 20years. This confirms the need to continue all efforts to disseminate the state of knowledge on climate change impacts in the Mediterranean region, such as water scarcity, especially to local water managers, as initiated by various research programs of the European Commission.
Collapse
Affiliation(s)
- I La Jeunesse
- University François Rabelais of Tours, UMR CNRS 7324 Citeres, 33, allée Ferdinand de Lesseps, B.P. 60449, 37204 Tours cedex 3, France; University of Angers, UMR CNRS 6554 LETG-Angers, 2 bd Lavoisier, 49045 Angers, France.
| | - C Cirelli
- University François Rabelais of Tours, UMR CNRS 7324 Citeres, 33, allée Ferdinand de Lesseps, B.P. 60449, 37204 Tours cedex 3, France
| | - D Aubin
- Université catholique de Louvain, Institut de sciences politiques Louvain-Europe, Place Montesquieu 1, b(te) L2.08.07, B-1348 Louvain-la-Neuve, Belgium
| | - C Larrue
- Université Paris-Est-Créteil-Val-de-Marne, Institut d'Urbanisme de Paris, 61, avenue du Général de Gaulle, 94010 Créteil cedex, France
| | - H Sellami
- Université catholique de Louvain, Earth and Life Institute, Croix du sud 2, bte 1, B-1348 Louvain-la-Neuve, Belgium
| | - S Afifi
- Islamic University of Gaza, Environmental & Earth Sciences Department, P.O. Box 108, Gaza, Palestine
| | - A Bellin
- University of Trento, Department of Civil, Environmental and Mechanical Engineering, Via Mesiano, 77 I-38123 Trento, Italy
| | - S Benabdallah
- Centre de Recherches et des Technologies des Eaux, Technopole Borj Cedria, BP 273, Soliman 8020, Tunisia
| | - D N Bird
- Joanneum Research Forschungsgesellschaft mbH, Leonhardstraße 59, A-8010 Graz, Austria
| | - R Deidda
- University of Cagliari, Faculty of Engineering, Piazza d'Armi, 09123 Cagliari, Italy; CINFAI, Consorzio Interuniversitario Nazionale per la Fisica delle Atmosfere e delle Idrosfere, Tolentino, Italy
| | - M Dettori
- Agricultural Research Agency of Sardinia (AGRIS-DIRVE), Sardinia, Viale Trieste 111, 09123 Cagliari, Italy
| | - G Engin
- Yildiz Technical University, Faculty of Civil Engineering, Department of Environmental Engineering, Davutpasa, Esenler, 34220 Istanbul, Turkey
| | - F Herrmann
- Forschungszentrum Jülich GmbH, Institut für Bio- und Geowissenschaften, Agrosphäre (IBG-3), Jülich, Germany
| | - R Ludwig
- Ludwig-Maximilians-Universität München (LMU), Department of Geography, Munich, Germany
| | - B Mabrouk
- University of Zagazig, Zagazig, Egypt
| | - B Majone
- University of Trento, Department of Civil, Environmental and Mechanical Engineering, Via Mesiano, 77 I-38123 Trento, Italy
| | - C Paniconi
- INRS, Centre Eau Terre Environnement, 490 rue de la Couronne, Quebec City G1K 9A9, Canada
| | - A Soddu
- Agricultural Research Agency of Sardinia (AGRIS-DIRVE), Sardinia, Viale Trieste 111, 09123 Cagliari, Italy
| |
Collapse
|
13
|
Curigliano G, Spitaleri G, Dettori M, Locatelli M, Scarano E, Goldhirsch A. Vaccine immunotherapy in breast cancer treatment: promising, but still early. Expert Rev Anticancer Ther 2014; 7:1225-41. [PMID: 17892423 DOI: 10.1586/14737140.7.9.1225] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Cancer vaccine-based immunotherapy should potentiate immunosurveillance function, preventing and protecting against growing tumors. Tumor cells usually activate the immune system, including T lymphocytes and natural killer cells, which are able to eliminate the transformed cells. Immunosubversion mechanisms related to tumor cells antigenic immunoediting induces mechanisms of tolerance and immunoescape. This condition impairs not only host-generated immunosurveillance, but also attempts to harness the immune response for therapeutic purposes. Most trials evaluating breast cancer vaccines have been carried out in patients in the metastatic and adjuvant setting. The aim of this review is to analyze the activity of vaccination strategies in current clinical trials. We summarize the differential approaches, protein-based and cell-based vaccines, focusing on vaccines targeting HER2/neu protein. Another focus of the review is to provide the reader with future challenges in the field, taking into account both the immunological and clinical aspects to better target the goal.
Collapse
Affiliation(s)
- Giuseppe Curigliano
- European Institute of Oncology, Department of Medicine, Division of Medical Oncology, Via Ripamonti 435, 20141 Milan, Italy.
| | | | | | | | | | | |
Collapse
|
14
|
Maida A, Castiglia P, Ciappeddu PL, Cossu A, Deriu GM, Dettori M, Muresu E, Piana A. [Assessment of seawater quality along the Asinara Gulf. Note 1: preliminary results of seawater monitoring using Dicentrarchus labrax and Sparus aurata as bioindicators]. Ann Ig 2010; 22:19-27. [PMID: 20476660] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
In recent years, physical-chemical, chemical and microbiological testing systems to water's control was matched by the use of "biomarkers" such as algae, nematodes, Anellidi, Porifera, molluscs and arthropods (crustaceans), although these are phylogenetically distant from humans and they differ in methods of recruitment, toxico-kinetics and metabolism of xenobiotics. That is why today the predatory fishes (tuna, mackerel, sea bream, sea bass and swordfish) are among the most widely used in biomonitoring studies. In particular Sparus aurata and Dicentrarchus labrax (sea bream and sea bass) are appropriate in warning of environmental pollution. Moreover since the two species are precious and particularly present in food, they could represent a potential vehicle for the transport of contaminants to humans. To this end, the aim of this note, part of a complex research project launched in line with the provisions of the ministry for the environment, land and sea, is to evaluate the quality of coastal waters by using of Sparus aurata and Dicentrarchus labrax. The results obtained show that the area concerned, at present, is not affected by serious pollution processes, as the human pressure is highlighted by the presence of phenols in sea water and heavy metals (Cd and Hg) in the bioindicators. The detection of these toxic elements in fish species, could also not be directly attributable to any condition of impairment of the environment. However given the accumulation of these contaminants in the parts are edible, the consumption of fish could be a source of exposure particularly for those most exposed to health risks (children, elderly, sick and pregnant women).
Collapse
Affiliation(s)
- A Maida
- Istituto di Igiene e Medicina Preventiva, Università degli Studi di Sassari
| | | | | | | | | | | | | | | |
Collapse
|
15
|
Vacca G, Ouled Ahmed Ben Ali H, Pazzola M, Sanna M, Dettori M, Carcangiu V. An investigation on allele frequency at the CSN1S2 locus and its relationship with milk parameters in the Sarda goat. J Anim Feed Sci 2009. [DOI: 10.22358/jafs/66437/2009] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
16
|
Masia MD, Dettori M, Liperi G, Deriu GM, Posadino S, Maida G, Mura I. [Thermal comfort in perioperatory risk's evaluation]. Ann Ig 2009; 21:251-258. [PMID: 19798902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
Studies till now conducted about operating rooms' microclimate have been focused mainly on operators' thermal comfort, considering that uneasiness conditions may compromise their working performance. In last years, nevertheless, the anesthesiologic community recalled attention on patients' risks determined by perioperatory variations of normothermia, underlining the necessity of orientating studies to individuate microclimate characteristics act to guarantee thermal comfort of the patient too. Looking at these considerations, a study has been conducted in the operating rooms of the hospital-university Firm and the n.1 USL of Sassari, finalized, on one hand, to determinate microclimate characteristics of the operating blocks and to evaluate operators' and patients' thermal comfort, on the other to individuate, through a software simulation, microclimate conditions that ensure contemporarily thermal comfort for both the categories. Results confirm the existence of a thermal "gap" among operators and patients, these last constantly submitted to "cold-stress", sometimes very accentuated. So, we underline microclimate's importance in operating rooms, because there are particular situations that can condition perioperatory risks. Moreover it can be useful to integrate risk's classes of the American Society of Anestesiology (ASA) with a score attributed to the PMV/PPD variation, reaching more real operatory risk indicators.
Collapse
Affiliation(s)
- M D Masia
- Istituto di Igiene e Medicina Preventiva, Università degli Studi di Sassari.
| | | | | | | | | | | | | |
Collapse
|
17
|
|
18
|
Rocca A, Dellapasqua S, Pietri E, Dettori M, D’Alessandro C, Ghisini R, Colombo A, Goldhirsch A, Colleoni M. Metronomic chemotherapy with capecitabine and oral cyclophosphamide in combination with bevacizumab in metastatic breast cancer (mbc): Evidence of activity of an antiangiogenic treatment. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.11501] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
11501 Background: Metronomic chemotherapy has shown efficacy in patients (pts) with MBC. Laboratory and clinical studies suggest that the combination with a specific antiangiogenic drug may be particularly effective. Methods: We evaluated the activity and biological effects of low dose continuous oral Capecitabine (500 mg PO TID) and Cyclophosphamide (50 mg PO QD) plus Bevacizumab (10 mg/Kg Q 2 weeks) in a two stage phase II trial in MBC pts, who received =3 lines of chemotherapy for advanced disease. Planned sample size is 46 pts. Results: To date, 26 patients have been enrolled on the study and 23 are evaluable. Pts characteristics: 1/2/=3 sites of metastatic disease 6/9/11 pts; dominant sites of disease soft tissues/bone/viscera 1/11/22; previous treatment for MBC: endocrine/chemo/trastuzumab 13/21/1 pts (=2 lines 25). Results: there were 1 CRs (4.3%), 10 PRs (43.5%), 6 SD (26.1%), and 6 PD (26.1%), for an overall response rate of 48% (exact 95% CI 27–69%). Median progression free survival was 6 months (+). Grade 3 side effects: 6 hypertension , 1 leucopenia , 2 neutropenia , 2 transaminitis (both with liver metastases). No patient was withdrawn from the study due to side effects, and hypertension was manageable with adequate therapy. Data on median circulating endothelial cells (CECs) will be available. Conclusions: Metronomic chemotherapy with capecitabine and cyclophosphamide in combination with bevacizumab has clinical activity and low toxicity in advanced breast cancer. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- A. Rocca
- European Institute of Oncology, Milan, Italy
| | | | - E. Pietri
- European Institute of Oncology, Milan, Italy
| | - M. Dettori
- European Institute of Oncology, Milan, Italy
| | | | - R. Ghisini
- European Institute of Oncology, Milan, Italy
| | - A. Colombo
- European Institute of Oncology, Milan, Italy
| | | | - M. Colleoni
- European Institute of Oncology, Milan, Italy
| |
Collapse
|
19
|
Masia MD, Solinas G, Piana A, Dettori M, Sotgiu G, Castiglia P. [Smoking habit and behaviour among health professionals]. Ann Ig 2006; 18:261-9. [PMID: 16821503] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/10/2023]
Abstract
The study reports the results of a survey by questionnaire on the health staff's smoking habits in the Hospital-University Complex of Sassari. Thirty-one percent are smokers: 35.5% among nurses, 21.4% among doctors and 40.4% among service staff. Daily smokers are 87.2% and 46% smoke 10 or more cigarettes per day. The great part of the sample thinks that it has to participate in tobacco control programs, although 6.0% of doctors disagree. Multiple correspondence analysis showed different profiles on attitudes and smoking habits among health staff components. Among no-smokers, nurses, technicians and service staff are not favorable to the tobacco control campaigns thinking they should not be a role model to others. Among smokers, service staff and some physicians showed a similar profile; moreover, they smoke in front of patients. These results indicate that the smoking attitude of some health staff components might be a "negative" model to which refer and it might interfere with tobacco control programs.
Collapse
Affiliation(s)
- M D Masia
- Istituto di Igiene e Medicina Preventiva, Università degli Studi di Sassari.
| | | | | | | | | | | |
Collapse
|
20
|
Maida A, Solinas G, Masia MD, Diana M, Dettori M, Pirastu R, Castiglia P. [Epidemiological survey on smoking habit among young students in Sardinia. A cross sectional study]. Ann Ig 2005; 17:209-17. [PMID: 16041923] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/03/2023]
Abstract
The study reports the prevalence of cigarette smoking among 11401 high school Sardinian students. The prevalence of smokers (40.2%) significantly differs between gender (41.1% males and 38.4% females). Males have an early initiation of smoking with an evident addictive effect by age. 54.3% are daily smokers and 21.4% smoke 15 or more cigarettes per day. More than 50% smoke to look grown-up and to be accepted by the group. Besides age (OR=1.10; 95%CI: 1.06-1.15), other factors are associated with smoke: low education level of father (OR=1.08; 95%CI: 1.02-1.15), no maternal support (OR = 1.73; 95%CI: 1.17-2.54), to have at least one smoker cohabitant (OR=1.66; 95%CI: 1.54-1.80) and alcohol drinking (OR=3.46; 95%CI: 3.04-3.93). The smokers' knowledge on smoke topics significantly differ from non smokers. Our results suggest the need of community preventive interventions, diversified for specific target populations, to modify the students' behaviours so that they respect their own health and that of their fellow citizens.
Collapse
Affiliation(s)
- A Maida
- Istituto di Igiene e Medicina Preventiva, Università degli Studi di Sassari.
| | | | | | | | | | | | | |
Collapse
|
21
|
Castiglia P, Solinas G, Sotgiu G, Palmieri A, Maida A, Dettori M. Epidemiology of hydatidosis in the province of Sassari, Italy. Parassitologia 2004; 46:371-3. [PMID: 16044693] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/03/2023]
Abstract
Cystic echinococcosis is endemic in certain parts of the world, including Sardinia, Italy. It was performed a study in the province of Sassari in order to evaluate the incidence of the infection in man and the effects of control programs since 1964 to 2002. Data obtained by surgical records, hospital discharge forms, radiological and pathological files were collected using a case report form. During the years 1964-2002, 2702 new cases were identified (average annual incidence: 17 per 100,000) and 1981 (73.3%) were submitted to surgical treatment. In 57.3% municipalities no cases were observed during the years 1998-2002. Males are more affected (56.2%), mostly farmers-shepherdess (68.6 per 100,000) and pensioners (59.6 per 100,000). Control measures led to a significant decline in the incidence rate of hydatidosis during the period 1964-2002, dropping by 27.6 per 100,000. The mean age of surgical patients increased during the years of surveillance, such as the surgical liver/lung ratio as a consequence of a cohort effect. The durability of control programs is the corner stone for obtaining a significant decrease of this infection.
Collapse
Affiliation(s)
- P Castiglia
- Institute of Hygiene and Preventive Medicine, University of Sassari, Italy.
| | | | | | | | | | | |
Collapse
|
22
|
Vacca G, Carcangiu V, Dettori M, Bini P. Relationships between body condition score, milk
yield and milk composition of Sarda goat. J Anim Feed Sci 2004. [DOI: 10.22358/jafs/74097/2004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
23
|
Dettori M, Carcangiu V, Cengarle L, Tilloca G, Manca R, Vacca G. Fatty acid profile of lamb <i>semitendinous</i> muscle
and perirenal adipose tissue from two different
genotypes. J Anim Feed Sci 2004. [DOI: 10.22358/jafs/74090/2004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
24
|
Strambi M, Paciotti F, Longini M, Dettori M. Selenium and hypertension: preliminary data. J Hum Hypertens 1994; 8:397. [PMID: 8064790] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Affiliation(s)
- M Strambi
- Istituto di Pediatria Sociale e Pureicultura, Universitita degli Studi di Siena, Italy
| | | | | | | |
Collapse
|
25
|
Dettori M, Strambi M. [Sex behavior and education in the adolescent. Relevant aspects in a cognitive study on a sample of Siena students]. Minerva Pediatr 1987; 39:965-6. [PMID: 3452761] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
|
26
|
Vierucci A, Monterisi N, Dettori M, Niccoli P, Petriccioli G. [Cholestasis lipoprotein (LP-X). Characteristics, diagnostic value and distribution in some liver diseases in children]. Minerva Pediatr 1974; 26:131-43. [PMID: 4206814] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
27
|
Dettori M, Malandrini F. [Clinical aspects and remote sequelae of neonatal hypoglycemias]. Minerva Pediatr 1973; 25:459-65. [PMID: 4705041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
28
|
Ragazzini F, Vierucci A, Dettori M. [Immunoglobulins: structure and genetics]. Minerva Pediatr 1970; 22:771-93. [PMID: 4102346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
|
29
|
Ragazzini F, Dettori M, Vierucci A. [Physiology of immunopoiesis]. Minerva Pediatr 1970; 22:794-830. [PMID: 4102347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
|
30
|
La Cauza C, Dettori M, Panero C. [Epidemiology of rheumatic disease in the Province of Siena]. Riv Clin Pediatr 1968; 81:1280-4. [PMID: 5759410] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
31
|
Dettori M, La Cauza C, Cantarini A. [Alkaline therapy in the asphyctic syndrome of the newborn]. Riv Clin Pediatr 1968; 81:1285-91. [PMID: 5759411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
32
|
Vierucci A, Blumberg BS, Dettori M, Borgatti L, Levene C. Isoantibodies to inherited types of beta-lipoproteins (Ag) and immunoglobulins (Gm and Inv). Serological and clinical aspects. J Pediatr 1968; 72:776-89. [PMID: 4172382 DOI: 10.1016/s0022-3476(68)80429-9] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
33
|
|
34
|
Vierucci A, Dettori M, Morganti G, Beolchini P, Bütler R. Synthesis of β-Lipoproteins (Ag Groups) in the Foetus
and the Newborn. Vox Sang 1968. [DOI: 10.1159/000464677] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
35
|
Vierucci A, Dettori M, Morgese G. [Demonstration of the fetal synthesis of immunoglobulins by means of determination of the Gm groups in immunoglobulin G fractions of umbilical cord blood]. Minerva Pediatr 1967; 19:600-1. [PMID: 4167694] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
36
|
Dettori M, Vierucci A, Varone D. [Human serum alpha-1-antitrypsin deficiency. (Apropos of 2 cases with transient deficiency)]. Riv Clin Pediatr 1966; 77:241-9. [PMID: 5962812] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
37
|
Dettori M, Vierucci A, Varone D, Borgatti L. [Immunoelectrophoretic study of the plasma proteins in children with Cooley's disease]. Riv Clin Pediatr 1966; 77:195-212. [PMID: 5955456] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
38
|
Vierucci A, Varone D, Borgatti L, Dettori M. [Classification of anti-Gm antibodies as 7S or 19S immunoglobulins in children with thalassemia treated with multiple transfusions]. Boll Soc Ital Biol Sper 1965; 41:127-30. [PMID: 5875550] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
39
|
Dettori M, Vierucci A, Varone D. [Values of the A2 hemoglobin fraction determined by DEAE Sephadex chromatography in newborn infants, infants and children with Cooley's disease]. Riv Clin Pediatr 1964; 74:614-8. [PMID: 5851607] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
40
|
Dettori M, Varone D, Vierucci A, Sangiorgi A. [Hemoglobin fraction A2 in normal and microcythemic subjects: comparative studies by means of column chromatography on DEAE Sephadex and electrophoresis on starch block and on paper]. Riv Clin Pediatr 1964; 74:249-56. [PMID: 5858278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|